Renaissance Technologies
AUGX

Renaissance Technologies’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Renaissance Technologies’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-53,200
Closed -$46.8K – 3982
2024
Q2 		$46.8K Sell
53,200
-27,000
-34% -$55.7K ﹤0.01% 3301
2024
Q1 		$328K Sell
80,200
-171,900
-68% -$769K ﹤0.01% 3053
2023
Q4 		$1.48M Buy
+252,100
New +$1.33M ﹤0.01% 2151
2023
Q3 		– Sell
-70,600
Closed -$340K – 4214
2023
Q2 		$340K Buy
+70,600
New +$244K ﹤0.01% 3077

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Renaissance Technologies's AUGX Position: Q3 2024 in Review

Renaissance Technologies sold out of Augmedix, Inc. Common Stock (AUGX) in Q3 2024, closing a stake of 53,200 shares — an estimated $46.8K sold.

Renaissance Technologies first reported a position in AUGX in Q2 2023 and held it in 4 quarters. The position peaked at $1.48M in Q4 2023. 45 funds tracked by Wall St. Rank hold AUGX as of Q3 2024.

  • Renaissance Technologies reported no remaining Augmedix, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Renaissance Technologies sold 53,200 Augmedix, Inc. Common Stock shares in Q3 2024, an estimated $46.8K.
  • Renaissance Technologies first reported a position in Augmedix, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • Renaissance Technologies's Augmedix, Inc. Common Stock position peaked at $1.48M in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q3 2024.

Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.